Skip to main content
TipRanks
Go Ultimate75% OFF

Swiss Re (SSREY) AI Stock Analysis

78 Followers
SSREY

Swiss Re

(Other OTC:SSREY)

Select Model
Rating:81Outperform
Price Target:$53.00â–²(19.11% Upside)
Action:reiterated
Date:11/08/26

The overall score of 81 reflects a high-quality company with strong financials and positive momentum. The most significant factors are the company's excellent underwriting performance and robust capital position, as highlighted in the earnings call, supported by a very strong balance sheet. The attractive valuation and positive technical trend further bolster the score. The primary risk to monitor is the decline in new business profitability, which tempers an otherwise very positive outlook.

Positive Factors
Strong capital and leverageSwiss Re’s materially lower leverage and very strong solvency position provide resilience through catastrophe and underwriting cycles. Strong capitalization also supports continued risk-taking, client confidence, capital returns, and investment in the business without placing excessive pressure on the balance sheet.
Negative Factors
Declining new-business CSMLower new-business CSM across all major segments signals weaker expected profitability from recently written business and a more challenging growth environment. If sustained, reduced value creation at inception could limit future CSM releases and weaken earnings momentum beyond the current period.

Swiss Re (SSREY) vs. SPDR S&P 500 ETF (SPY)

-15%-10%-5%0%5%10%15%20%25%SSREY+7.18%SPY+13.11%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$52.47B
Dividend Yield
4.52%
Average Volume (3M)
25.07K
Price to Earnings (P/E)
10.7
Beta (1Y)
0.33
Revenue Growth
-3.85%
EPS Growth
30.01%
Country
US
Employees
14,893
Sector
Financial
Sector Strength
68
Industry
Insurance - Reinsurance

Swiss Re Business Overview & Revenue Model

Company Description

Swiss Re AG, along with its affiliated entities, operates internationally as a prominent provider of diverse risk management solutions. Its offerings extend to wholesale reinsurance, direct insurance products, various forms of insurance-based risk tr...

How the Company Makes Money

Swiss Re primarily makes money by taking on insurance risk from other insurers (and, in some businesses, directly from customers) in exchange for premiums, and by investing the assets it holds to pay future claims. A key revenue stream is reinsurance...

Swiss Re Earnings Call Summary

Earnings Call Date:Aug 06, 2026(Q2-2026)|% Change Since:5.40%|Next Earnings Date:Feb 26, 2027
Earnings Call SentimentPositive

The call presented a predominantly positive operational and financial picture: strong H1 net income (USD 2.8B), high ROE (23%), robust P&C combined ratio (76.7%), solid Life & Health Re results, healthy investment returns (4.0% ROI) and a very strong capital position (SST ~264%). Management also announced an increased cost-reduction target and continued active capital return (buyback). Offsetting risks include notable declines in new business CSM across segments, pricing pressure in specific lines (non-proportional property, parts of Specialty, Corporate rates), rising P&C expense ratio, and questions about the sustainability of large short-tail reserve releases. Overall, the positives (underwriting results, capital, investments, cost discipline) materially outweigh the headwinds related to new-business profitability and selective pricing pressure, but the latter warrant monitoring going into 2027.

Positive Updates

Strong Net Income and Capital Position
Reported net income of USD 2.8 billion for H1 2026 (more than 60% of the full-year target of USD 4.5 billion) and an estimated group SST ratio of 264% (up 14 percentage points since Jan 1, 2026), indicating a very strong capital position.

Negative Updates

Decline in New Business CSM Across Segments
New business CSM reductions year-on-year: P&C Re USD 1.6B vs USD 2.2B (down ~27%), Corporate Solutions USD 201M vs USD 262M (down ~23%), Life & Health Re USD 338M vs USD 569M (down ~41%), reflecting lower transaction activity and a more challenging new-business environment.

Company Guidance

Management reiterated a full‑year net income target of USD 4.5bn (H1 net income USD 2.8bn, >60% of target) and highlighted strong H1 metrics — group ROE 23% — while setting specific business targets and near‑term expectations: Life & Health H1 net income just over USD 1.0bn with a 2026 net income target of USD 1.7bn, an insurance service result of USD 1.2bn and a CSM release of USD 758m (annualized ~9%); P&C Re H1 insurance service result USD 1.8bn, combined ratio 76.7% (full‑year target <85%), new business CSM USD 1.6bn (vs USD 2.2bn prior) and USD 6–7bn of treaty renewals to end‑June; Corporate Solutions H1 combined ratio 86.1%, insurance service result USD 578m, CSM release ~USD 400m and new business CSM USD 201m (vs USD 262m prior); midyear renewals showed 11% volume growth and year‑to‑date premium volume +0.5% with nominal pricing broadly flat (casualty mid‑single‑digit increases, non‑prop property down high single digits), year‑to‑date loss assumptions +4.4% (explaining a ~4.6% risk‑adjusted price decline), investment ROI 4.0% with recurring income USD 2bn, estimated group SST 264% (up 14pp since Jan, ~5pp temporary benefit), ~60% of a USD 1.5bn buyback executed, an increased operating cost‑saving target of USD 500m by 2028 (run‑rate, reflected in FY2029), and management expects mid‑triple‑digit reserve releases to help offset renewal headwinds.

Swiss Re Financial Statement Overview

Summary

Financial health is strong, driven by a robust balance sheet (Score: 90) with low leverage and high solvency, and an improving income statement (Score: 85) with expanding margins. Cash flow (Score: 78) is positive but shows some volatility in conversion, tempering the overall score slightly.

Income Statement

85Very Positive

Balance Sheet

90Very Positive

Cash Flow

78Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue47.22B48.19B46.76B43.64B46.04B45.94B
Gross Profit31.10B48.19B43.14B40.32B38.24B37.70B
EBITDA7.03B6.59B4.27B4.26B1.65B3.07B
Net Income5.01B4.76B3.24B3.11B472.00M1.44B
Balance Sheet
Total Assets132.85B134.01B127.23B179.58B170.68B181.57B
Cash, Cash Equivalents and Short-Term Investments3.93B2.74B88.64B88.38B85.61B4.15B
Total Debt9.45B8.98B7.26B9.82B11.04B11.19B
Total Liabilities108.33B108.71B103.99B163.21B157.87B157.89B
Stockholders Equity24.46B25.11B23.11B22.31B12.70B23.57B
Cash Flow
Free Cash Flow2.37B3.04B3.13B4.09B2.93B4.10B
Operating Cash Flow2.37B3.04B3.13B4.09B2.93B4.10B
Investing Cash Flow1.94B-2.29B-407.00M-362.00M-2.34B-2.14B
Financing Cash Flow-4.00B-2.14B-2.97B-3.22B-1.24B-2.10B

Swiss Re Technical Analysis

Technical Analysis SentimentNeutral
Last Price44.50

Price Trends

50DMA44.34Positive
100DMA43.26Positive
200DMA41.47Positive

Market Momentum

MACD0.15Positive
RSI43.09Neutral
STOCH3.19Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SSREY, the sentiment is Neutral. The current price of 44.50 is below the 20-day moving average (MA) of 46.14, above the 50-day MA of 44.34, and above the 200-day MA of 41.47, indicating a neutral trend. The MACD of 0.15 indicates Positive momentum. The RSI at 43.09 is Neutral, neither overbought nor oversold. The STOCH value of 3.19 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for SSREY.

Swiss Re Peers Comparison

Overall Rating

UnderperformOutperform
Sector (68)

Financial Indicators

SSREY against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
SSREYSSREY81Outperform$48.86B10.7420.19%4.52%-3.85%30.01%
ACGLACGL81Outperform$35.55B8.7718.35%―-5.29%14.08%
SPNTSPNT80Outperform$2.98B6.2321.64%―18.14%163.19%
RGARGA78Outperform$17.27B10.1513.15%1.44%22.58%99.93%
RNRRNR76Outperform$14.01B9.8713.52%0.47%-21.18%-3.27%
Sector *68Neutral$18.00B11.429.92%3.81%9.73%1.22%
EGEG65Neutral$15.56B8.9412.52%1.90%-8.72%250.85%

* Financial Sector Average

Performance Comparison

0%20%40%SSREYACGLEGRGARNRSPNTDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
SSREY and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
SSREYSwiss Re AG44.503.147.60%
ACGLArch Capital108.6216.7418.22%
EGEverest Group, Ltd.420.04122.2841.07%
RGAReinsurance Group Of America265.5583.7046.03%
RNRRenaissancere346.8186.7533.36%
SPNTSiriuspoint Ltd25.926.1731.24%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 07, 2026